Drug Type Biological products |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization AntlerA Therapeutics, Inc.Startup |
Active Organization AntlerA Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bone Diseases | Preclinical | CA | AntlerA Therapeutics, Inc.Startup | 12 Apr 2024 |
Eye Diseases | Preclinical | CA | AntlerA Therapeutics, Inc.Startup | 12 Apr 2024 |
Lung Diseases | Preclinical | CA | AntlerA Therapeutics, Inc.Startup | 12 Apr 2024 |